Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Barrick Gold Corp (B) vs Invesco Ltd. (IVZ) Price & Performance

Barrick Gold CorpTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Barrick Gold Corp vs Invesco Ltd. — how do they compare? Barrick Gold Corp trades at $40.8 (market cap $68.49B), while Invesco Ltd. trades at $31.16 (market cap $14.01B). The key difference: Barrick Gold Corp is far larger — about 4.9× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.71%). Which is the better fit depends on your goals.

BIVZ
Market Cap
$68.49B$14.01B
Sector
Basic MaterialsFinancials
52-Week High
$52.97$32.01
52-Week Low
$23.50$20.67
Enterprise Value
$66.08B$24.18B
Dividend Yield
1.71%2.71%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Barrick Gold Corp

Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.

Read more on B

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ